Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-18

FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Emtriva (emtricitabine) submitted by Gilead Sciences, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtriva (emtricitabine)

Snippet

SUPPL AP for EMTRIVA (EMTRICITABINE)